Siteman Cancer Center established a Good Manufacturing Practice (GMP) facility
In 2004, the Siteman Cancer Center established a Good Manufacturing Practice (GMP) facility, the first built in partnership…
Cialis Was Approved by the FDA
On Nov. 21, 2003, Cialis (tadalafil), discovered through a Glaxo Wellcome and ICOS Corp. partnership, was first approved…
Results of the Prostate Cancer Prevention Trial were announced
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
Taking daily aspirin for as little as 3 years was shown to reduce the development of colorectal polyps
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
Cialis, a medication to treat male erectile dysfunction, was approved for marketing in the European Union
On Nov. 12, 2002, Cialis, a medication to treat male erectile dysfunction, manufactured by Eli Lilly and Company,…
Diagnostics | FDA | Medicine | Pharmaceutical | Therapeutics
The Best Pharmaceuticals for Children Act improved safety and efficacy of patented and off-patent medicines for children
In 2002, the U.S. Congress passed the Best Pharmaceuticals for Children Act that improved safety and efficacy of…
Corus Pharma was incorporated
On Jan. 12, 2001, Corus Pharma was incorporated as a private venture-backed development stage biopharmaceutical company focused on…
Wyeth Lederle Vaccines voluntarily withdrew Rotashield from the market
On Oct. 15, 1999, Wyeth-Lederle Vaccines announced that it was withdrawing the Rotashield vaccine from the market and…
Gilead Sciences and NeXstar Pharmaceuticals announced completion of their merger
On Jul. 29, 1999, Gilead Sciences and NeXstar Pharmaceuticals announced the closing of their agreement whereby Gilead acquired…
The Tennessee Biotechnology Association was established
On Apr. 15, 1999, the Tennessee Biotechnology Association (TBA), now the Life Science Tennessee, was established. The Tennessee…
ZymoGenetics was instrumental in development of new hemophilia drug
On Mar. 27, 1999, Novo Nordisk, the ZymoGenetics parent company, announced approval of NovoSeven by the Food and…
National Black HIV/AIDS Awareness Day was founded
On Feb. 7, 1999, National Black HIV/AIDS Awareness Day was founded by five national organizations funded by the…
Jane E Henney, MD, becomes the first woman Commissioner of Food and Drugs
On Jan. 17, 1999, Jane E. Henney, M.D., appointed by President Bill Clinton, became the first woman to…
American Association for Cancer Research Scientist-Survivor Program was founded
In 1999, American Association for Cancer Research (AACR) Scientist-Survivor Program which united researchers with patients and survivor advocates…
Trubion Pharmaceutical was founded
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…
LigoCyte Pharmaceuticals was founded
In 1998, LigoCyte Pharmaceuticals was founded in Bozeman by Robert F. Bargatze, Ph.D., and John W. Jutila, Ph.D….
The U.S. FDA approved direct to consumer advertising
On Aug. 9, 1997, the U.S. Food and Drug Administration (FDA) announced a policy that allowed pharmaceutical companies…
Bristol-Myers Squibb opened a 433-acre research campus in Hopewell, New Jersey
In 1997, Bristol-Myers Squibb opened a 433-acre research campus in Hopewell, New Jersey. Two important new medicines co-developed…
Texas Healthcare & Bioscience Institute was founded
In 1996, Texas Healthcare & Bioscience Institute (THBI) was founded in Austin. The mission of the Texas Healthcare…
Proposed reforms to reduce regulatory burden on pharmaceutical manufacturers were announced
On Sept. 27, 1995, a series of proposed reforms to reduce regulatory burden on pharmaceutical manufacturers were announced….
Bristol-Myers’ Wallingford facility named the Richard L Gelb Center for Pharmaceutical R&D after former Bristol-Myers chair and CEO
In 1995, Bristol-Myers’ Wallingford, Connecticut facility was named the Richard L. Gelb Center for Pharmaceutical Research and Development…
Generic Drug Enforcement Act imposed debarment and other penalties for illegal acts involving abbreviated drug applications
On May 13, 1992, the U.S. Congress announced the Generic Drug Enforcement Act, sponsored by Rep. John Dingell…
The California Supreme Court ruled that a patient does not have rights to profits derived from his cell line
In 1990, the California Supreme Court rules in the case involving Seattle’s John Moore that a patient does…
Agriculture | Biotechnology | Diagnostics | Medical Device | Non-Profit Research | Pharmaceutical | Therapeutics | Veterinary
BayBio was founded in San Francisco
In 1990, BayBio, a non-profit 501(c)(3) organization headquartered in San Francisco, was founded by a consortium of universities,…
The Washington Association for Biomedical Research was founded
In 1989, the Washington Biotechnology & Biomedical Association, now known as Life Science Washington, was founded by local…
The Prescription Drug Marketing Act banned the diversion of prescription drugs from legitimate commercial channels
On Apr. 22. 1988, the Prescription Drug Marketing Act of 1987 (PDMA) was signed into law by the…
Investigational drug regulations revised to expand access to experimental drugs for patients with no alternative therapies
In 1987, the U.S. Food and Drug Administration (FDA) announced revised regulations regarding Expanded Access (EA) to investigational…
Genetic Systems acquired by Bristol-Myers for $310 million
On Feb. 4, 1986, Bristol-Myers announced it would acquire Genetic Systems for $310 million. Genetic Systems was a…
The Hatch-Waxman Act was passed to encourage development of generic prescription drugs
On Sept. 24, 1984 the Hatch-Waxman Act (Drug Price Competition and Patent Term Restoration Act) was passed to…
A policy statement regarding the relationship of NCI, the pharmaceutical industry, and NCI-supported cooperative groups was developed
In 1984, a policy statement regarding the relationship of National Cancer Institute (NCI), the pharmaceutical industry, and NCI-supported…